Clinical Trial Update: The ATLANTA First in Man Study of the Catania Stent [Phase 1]

View source ↗

Summary

The ATLANTA first-in-man Phase 1 study of the Catania Stent for coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Catania Stent

Snippet

Sponsor: CeloNova BioSciences, Inc. | Conditions: Coronary Artery Disease | Phase 1 | Status: COMPLETED